Education
About Us
Working with TipRanks
Follow Us
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
| Dec 23 | Dec 22 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 |
| Operating Income | $ -4.68M | $ -3.86M |
| EBITDA | $ -4.64M | $ -3.80M |
| Net Income | $ -4.94M | $ -3.21M |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 4.59M | $ 8.26M |
| Total Assets | $ 5.26M | $ 9.33M |
| Total Debt | $ 171.00K | $ 271.00K |
| Net Debt | $ -4.42M | $ -7.99M |
| Total Liabilities | $ 17.31M | $ 16.41M |
| Stockholders' Equity | $ -15.48M | $ -10.66M |
| Cash Flow | ||
| Free Cash Flow | $ -4.54M | $ -3.38M |
| Operating Cash Flow | $ -4.53M | $ -3.33M |
| Investing Cash Flow | $ 573.00K | $ -524.00K |
| Financing Cash Flow | $ 522.00K | $ 2.75M |